Study Published on Safety and Tolerability of Sabinsa’s Sabeet® Beetroot Extract in Older Populations

Sami-Sabinsa, a global leader in the nutraceutical and cosmeceutical industries, is pleased to announce the publication of a preliminary study evaluating the safety, tolerability, and health benefits of Sabeet®, a standardized beetroot extract, in older adults. Conducted in collaboration with the researchers of the Food and Nutrition Institute of Federal University of Rio de Janeiro, Brazil, the study demonstrated the safety and potential health benefits of daily beetroot extract supplementation over 12 weeks.
The study, published in the journal Nutrients, “Evaluation of 12-Week Standardized Beetroot Extract Supplementation in Older Participants: A Preliminary Study of Human Health Safety,” involved 12 older participants aged 60 and above. Participants were randomly assigned to receive either 20 grams of Sabeet® beetroot extract or a placebo daily for 12 weeks. Key parameters including anthropometric, biochemical, and hemodynamic measures were evaluated to assess safety and tolerability.
Key Findings
“This preliminary study was conducted to underscore the safety and tolerability of Sabeet®, but we are pleased to see the benefits it indicated as well,” said Shaheen Majeed, Global CEO & Managing Director of The Sami-Sabinsa Group. “These findings align with our commitment to providing scientifically backed, safe, and effective dietary supplements. Sami-Sabinsa extends its gratitude to the team in Food and Nutrition Institute at Federal University of Rio de Janeiro for their collaboration in this study, and we look forward to continuing collaboration.”
The study may be accessed here: https://doi.org/10.3390/nu16121942